Compare · ELV vs MSON
ELV vs MSON
Side-by-side comparison of Elevance Health Inc. (ELV) and MISONIX, Inc. (MSON): market cap, price performance, sector, and recent activity on the wire.
Summary
- ELV operates in Health Care, while MSON operates in Capital Goods - the two are in different parts of the market.
- ELV is the larger of the two at $81.91B, about 177.1x MSON ($462.5M).
- ELV has hit the wire 6 times in the past 4 weeks while MSON has been quiet.
- ELV has more recent analyst coverage (23 ratings vs 2 for MSON).
- Company
- Elevance Health Inc.
- MISONIX, Inc.
- Price
- $373.98-0.92%
- $26.23+3.72%
- Market cap
- $81.91B
- $462.5M
- 1M return
- -3.27%
- -
- 1Y return
- +31.02%
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NASDAQ
- IPO
- 1992
- News (4w)
- 6
- 0
- Recent ratings
- 23
- 2
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
MISONIX, Inc.
Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets minimally invasive surgical ultrasonic medical devices in the United States and internationally. The company's products include BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue; SonaStar, a surgical aspirator, which is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system that provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. Its products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, general surgery, plastic surgery, wound care, and maxillo-facial surgical applications. The company sells its products through sales representatives and distributors. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York.
Latest ELV
- Director Peru Ramiro G bought $366,050 worth of shares (1,000 units at $366.05), increasing direct ownership by 10% to 10,908 units (SEC Form 4)
- President and CEO Boudreaux Gail bought $1,002,230 worth of shares (2,725 units at $367.79), increasing direct ownership by 2% to 171,976 units (SEC Form 4)
- SEC Form 10-Q filed by Elevance Health Inc.
- Elevance Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Elevance Health Reports Second Quarter 2026 Results; Raises Full-Year Guidance
- Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter 2026 Results on July 15, 2026
- New Elevance Health Public Policy Institute Study Examines Payment Disputes for Planned Procedures Under the No Surprises Act
- Thomas Carr Howe Middle School Unveils New Fitness and Strength Training Space Through Partnership with Elevance Health and Impact Fitness Foundation
- Elevance Health Makes Clinical Review Faster, More Connected with Health OS
- SEC Form 11-K filed by Elevance Health Inc.
Latest MSON
- SEC Form 4: Koby Michael returned 1,744,017 shares to the company
- SEC Form 4: Vizirgianakis Stavros G. returned 2,136,478 shares to the company, closing all direct ownership in the company
- SEC Form 4: Patton Thomas M returned 104,500 shares to the company, closing all direct ownership in the company
- SEC Form 4: Ludecker Robert S returned 319,443 shares to the company, closing all direct ownership in the company
- SEC Form 4: Laviolette Paul A returned 1,744,017 shares to the company
- SEC Form 4: Dwyer Joseph P returned 276,200 shares to the company, closing all direct ownership in the company
- SEC Form 4: Beyer Pat returned 20,000 shares to the company, closing all direct ownership in the company
- SEC Form RW filed by MISONIX, Inc.
- SEC Form 15-12B filed by MISONIX, Inc.
- MISONIX, Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Control of Registrant, Leadership Update, Financial Statements and Exhibits